We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Curious about Dun & Bradstreet (DNB) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Dun & Bradstreet (DNB - Free Report) will report quarterly earnings of $0.32 per share in its upcoming release, pointing to no change from the year-ago quarter. It is anticipated that revenues will amount to $656.29 million, exhibiting an increase of 4.1% compared to the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 1.4% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Dun & Bradstreet metrics that are routinely monitored and predicted by Wall Street analysts.
The consensus among analysts is that 'Revenue- Sales & Marketing' will reach $283.20 million. The estimate suggests a change of +3.9% year over year.
The collective assessment of analysts points to an estimated 'Revenue- Finance & Risk' of $373.11 million. The estimate indicates a change of +4.3% from the prior-year quarter.
The combined assessment of analysts suggests that 'Revenue- North America' will likely reach $474.47 million. The estimate indicates a change of +3.9% from the prior-year quarter.
Analysts expect 'Revenue- North America- Finance & Risk' to come in at $249.41 million. The estimate suggests a change of +3.3% year over year.
It is projected by analysts that the 'Revenue- International' will reach $181.84 million. The estimate suggests a change of +4.8% year over year.
Analysts predict that the 'Revenue- International- Finance & Risk' will reach $123.70 million. The estimate points to a change of +6.3% from the year-ago quarter.
Analysts' assessment points toward 'Revenue- International- Sales & Marketing' reaching $58.14 million. The estimate points to a change of +1.6% from the year-ago quarter.
The consensus estimate for 'Revenue- North America- Sales & Marketing' stands at $225.06 million. The estimate points to a change of +4.5% from the year-ago quarter.
Based on the collective assessment of analysts, 'Adjusted EBITDA- International' should arrive at $58.50 million. Compared to the current estimate, the company reported $55.20 million in the same quarter of the previous year.
According to the collective judgment of analysts, 'Adjusted EBITDA- North America' should come in at $235.14 million. Compared to the present estimate, the company reported $223.70 million in the same quarter last year.
Over the past month, Dun & Bradstreet shares have recorded returns of -6.1% versus the Zacks S&P 500 composite's +4.7% change. Based on its Zacks Rank #4 (Sell), DNB will likely underperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Curious about Dun & Bradstreet (DNB) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Dun & Bradstreet (DNB - Free Report) will report quarterly earnings of $0.32 per share in its upcoming release, pointing to no change from the year-ago quarter. It is anticipated that revenues will amount to $656.29 million, exhibiting an increase of 4.1% compared to the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 1.4% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Dun & Bradstreet metrics that are routinely monitored and predicted by Wall Street analysts.
The consensus among analysts is that 'Revenue- Sales & Marketing' will reach $283.20 million. The estimate suggests a change of +3.9% year over year.
The collective assessment of analysts points to an estimated 'Revenue- Finance & Risk' of $373.11 million. The estimate indicates a change of +4.3% from the prior-year quarter.
The combined assessment of analysts suggests that 'Revenue- North America' will likely reach $474.47 million. The estimate indicates a change of +3.9% from the prior-year quarter.
Analysts expect 'Revenue- North America- Finance & Risk' to come in at $249.41 million. The estimate suggests a change of +3.3% year over year.
It is projected by analysts that the 'Revenue- International' will reach $181.84 million. The estimate suggests a change of +4.8% year over year.
Analysts predict that the 'Revenue- International- Finance & Risk' will reach $123.70 million. The estimate points to a change of +6.3% from the year-ago quarter.
Analysts' assessment points toward 'Revenue- International- Sales & Marketing' reaching $58.14 million. The estimate points to a change of +1.6% from the year-ago quarter.
The consensus estimate for 'Revenue- North America- Sales & Marketing' stands at $225.06 million. The estimate points to a change of +4.5% from the year-ago quarter.
Based on the collective assessment of analysts, 'Adjusted EBITDA- International' should arrive at $58.50 million. Compared to the current estimate, the company reported $55.20 million in the same quarter of the previous year.
According to the collective judgment of analysts, 'Adjusted EBITDA- North America' should come in at $235.14 million. Compared to the present estimate, the company reported $223.70 million in the same quarter last year.
View all Key Company Metrics for Dun & Bradstreet here>>>
Over the past month, Dun & Bradstreet shares have recorded returns of -6.1% versus the Zacks S&P 500 composite's +4.7% change. Based on its Zacks Rank #4 (Sell), DNB will likely underperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>